Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis

Author:

Lagares David1ORCID,Santos Alba1ORCID,Grasberger Paula E.1ORCID,Liu Fei2ORCID,Probst Clemens K.1ORCID,Rahimi Rod A.1ORCID,Sakai Norihiko13,Kuehl Tobias1,Ryan Jeremy4ORCID,Bhola Patrick4,Montero Joan4,Kapoor Mohit5ORCID,Baron Murray6ORCID,Varelas Xaralabos7,Tschumperlin Daniel J.28ORCID,Letai Anthony4,Tager Andrew M.1

Affiliation:

1. Fibrosis Research Center and Center for Immunology and Inflammatory Diseases, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

2. Molecular and Integrative Physiological Sciences Program, Harvard T. H. Chan School of Public Health, Boston, MA 02115, USA.

3. Division of Nephrology and Division of Blood Purification, Kanazawa University Hospital, Kanazawa, Japan.

4. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

5. Krembil Research Institute, University Health Network and Department of Surgery and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.

6. Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

7. Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.

8. Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, MN 55905, USA.

Abstract

ABT-263 blocks BCL-X L to induce apoptosis in human dermal fibroblasts from patients with scleroderma and in myofibroblasts in mice, reversing dermal fibrosis.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3